Latest Research in Oncolytic Vector Immunotherapy

Top Research Topics in Oncolytic Vector Immunotherapy

• CAR-T cell therapy research — 21 papers
• Monoclonal and Polyclonal Antibodies Research — 12 papers
• Immunotherapy and Immune Responses — 10 papers
• Immune Cell Function and Interaction — 6 papers
• Virus-based gene therapy research — 6 papers
• vaccines and immunoinformatics approaches — 5 papers
• Mathematical Biology Tumor Growth — 4 papers
• Liver physiology and pathology — 2 papers
• Prostate Cancer Treatment and Research — 2 papers
• HER2/EGFR in Cancer Research — 1 papers

Highest-Cited Papers

1. Lymphocytic Choriomeningitis Virus Bearing GPC Mutations for Enhanced Tumor Tropism and Strong Anti-Tumor Activity (1 citations)
2. Optimisation of in vitro assays for accurate risk assessment of T-cell responses to biologics with potential immune liabilities
3. Personalized neoantigen vaccine platform and longitudinal tracking of vaccine-related clonotypes enable the identification of tumor-specific TCRs
4. TCR-like MAGE-A4/HLA-A*02:01 CAR-NK cells enhance antitumor effector function and control melanoma xenografts
5. Genetically engineered dendritic cells in cancer immunotherapy: from immune reprogramming strategies to emerging CAR-DC platforms
6. Optimizing the Hinge Length of Chimeric Antigen Receptor with a DdFP-Based Immunological Synapse Biosensor
7. In vitro and in vivo antitumor activities of oHSV-BJ-2 oncolytic virus
8. Protocol for designing and evaluating antibody-drug conjugates to promote endocytosis and lysosomal trafficking
9. A Dual-Ligand PDC Co-Targeting FOLR1 and c-Met Enhances Tumor Accumulation and Antitumor Efficacy in Ovarian Cancer
10. Combination of PARP inhibitor olaparib and a vascular disrupting agent reduces tumor growth in a preclinical model of prostate cancer
11. A p53R273H-selective bispecific T cell engager: Computational design and functional validation.
12. Collagen‐Binding IL‐15 Immunocytokine Armed Oncolytic Adenovirus Establishes a Self‐Reinforcing Immunostimulatory Milieu to Potentiate Antitumor Immunity
13. Quantifying immunosuppressive barriers using a mathematical framework of tumor-associated myeloid cell mediated resistance in oncolytic virotherapy
14. Therapeutic Cancer Vaccines: Classification, Mechanisms, Challenges and Future Perspectives
15. FOXP1 Knockdown Reprograms Th9 CAR‐T Cells to Overcome Antigen Escape
16. Identification of mITGB2 as an MHC-II neoantigen using hepatocellular carcinoma organoids
17. ДИСКРЕТНІ МОДЕЛІ КЛІТИННИХ АВТОМАТІВ ДИНАМІКИ РОСТУ ПУХЛИНИ ТА ІМУННОГО НАГЛЯДУ
18. Immunopeptidomics-guided cancer vaccine design: Advances, challenges, and emerging opportunities
19. Molecular engineering and clinical translation of T cell engaging bispecific antibodies in cancer therapy
20. Personalized mRNA Neoantigen Vaccines in Cancer: Linking Precision Antigen Selection, Immune Remodeling, and Checkpoint Blockade

Sub-Regions

• CAR-T cell therapy research — 22 papers
• Mathematical Biology Tumor Growth — 15 papers
• Immunotherapy and Immune Responses — 14 papers
• Monoclonal and Polyclonal Antibodies Research — 13 papers
• Optimization and Control — 12 papers
• vaccines and immunoinformatics approaches — 9 papers